Seeking Alpha

Bayer Aktienges Ads (BAYRY.PK)

()

Comments on BAYRY.PK

  • Endo Pharma Gets a Setback [View article]
    so what is the conclusion for us investors ? should we buy it ? hold ? or sell it ? it s like putting a bunch of ingredients on the... More »
    Comment by tipalia
    Dec 12 08:51 am |
    Rating: 0 0
  • Diabetes Care: Global Investing Opportunities [View article]
    yes why not mentioned? On Nov 22 08:13 AM nougatine1 wrote: > And GNBT...
    Comment by fran grady
    Nov 22 11:51 am |
    Rating: +1 -1
  • Diabetes Care: Global Investing Opportunities [View article]
    The holy grail in the future of Diabetes and Obesity lies simply in two areas: 1. A pill to defeat obesity and 2. A Trans-Dermal... More »
    Comment by saber Tooth
    Nov 22 11:36 am |
    Rating: 0 -1
  • Diabetes Care: Global Investing Opportunities [View article]
    Mike, If I may ask a question... I have been looking at several penny stocks lately, one being SNBP. and I see where they are splitting... More »
    Comment by rob134
    Nov 22 10:58 am |
    Rating: 0 -1
  • Diabetes Care: Global Investing Opportunities [View article]
    And GNBT...
    Comment by nougatine1
    Nov 22 08:13 am |
    Rating: +2 -1
  • The World's Top Chemical Companies [View article]
    The much shrunken DuPont Company as it continues to decline is beginning to look more and more like the General Motors of chemicals! ... More »
    Comment by funfun
    Nov 3 16:00 pm |
    Rating: +2 -1
  • The World's Top Chemical Companies [View article]
    It is a good thing that size does not matter when it comes to making money on the stock market. Also look at GM and what happened to... More »
    Comment by mother_jones_husband
    Nov 3 11:22 am |
    Rating: +2 -1
  • The World's Top Chemical Companies [View article]
    Wow! DuPont which formerly was the largest, and unquestioned leader in the chemical industry has plunged from number one to number eight... More »
    Comment by funfun
    Nov 2 13:55 pm |
    Rating: +2 -1
  • Novartis: Powering into the Multiple Sclerosis Market [View article]
    Thank you for pointing out the error about Opexa and Novartis. The deal does not cover Tovaxin, the MS agent.
    Comment by Richard Sater
    Sep 9 08:26 am |
    Rating: 0 0
  • Bayer's Bold New Bet Fails to Rain on Spectrum Pharma [View article]
    There is really only one reason for the commercial failure of Zevalin (can't speak to Bexar).....which was eloquently described in the... More »
    Comment by biopharmabull
    Sep 8 18:10 pm |
    Rating: +1 0
  • Novartis: Powering into the Multiple Sclerosis Market [View article]
    MS Views and News (a 501©(3) organization) is dedicated to the global collection and distribution of current information concerning... More »
    Comment by msviews_andnews
    Sep 8 08:49 am |
    Rating: 0 0
  • Novartis: Powering into the Multiple Sclerosis Market [View article]
    Unique in what we do. Bridging the gap to all major MS Organizations. Providing information and resources from our website, daily via... More »
    Comment by msviews_andnews
    Sep 8 08:45 am |
    Rating: 0 0
  • Bayer's Bold New Bet Fails to Rain on Spectrum Pharma [View article]
    Actually, what is making news (and hence, the topic of the article) is that Bayer AG (BAYRY.PK) entered into an $800 million deal with... More »
    Comment by Michael Becker
    Sep 7 08:55 am |
    Rating: 0 0
  • Bayer's Bold New Bet Fails to Rain on Spectrum Pharma [View article]
    article has nothing to do with zevalin being approved for another indication ,which is what is making news ,its about bayer did not... More »
    Comment by User 482664
    Sep 6 17:07 pm |
    Rating: +1 -3
  • Bayer's Bold New Bet Fails to Rain on Spectrum Pharma [View article]
    Read the other articles by this guy. He's a professional SPPI basher and has been one for months. Personally I don't care; i just wonder... More »
    Comment by herbert hoover
    Sep 5 21:05 pm |
    Rating: +2 -2